Epizyme
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Epizyme and buy or sell other stocks, ETFs, and their options commission-free!About EPZM
Epizyme, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the discovery, development, and commercialization of novel epigenetic medicines for cancer and other diseases.
CEOGrant C. Bogle, MBA
CEOGrant C. Bogle, MBA
Employees—
Employees—
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2007
Founded2007
Employees—
Employees—
EPZM Key Statistics
Market cap247.44M
Market cap247.44M
Price-Earnings ratio-0.85
Price-Earnings ratio-0.85
Dividend yield—
Dividend yield—
Average volume4.24M
Average volume4.24M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$5.80
52 Week high$5.80
52 Week low$0.411
52 Week low$0.411
Stock Snapshot
Epizyme(EPZM) stock is priced at $1.47, giving the company a market capitalization of 247.44M. It carries a P/E multiple of -0.85.
During the trading day, Epizyme(EPZM) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading activity shows a volume of 0, compared to an average daily volume of 4.24M.
The stock's 52-week range extends from a low of $0.41 to a high of $5.80.
The stock's 52-week range extends from a low of $0.41 to a high of $5.80.
People also own
Based on the portfolios of people who own EPZM. This list is generated using Robinhood data, and it’s not a recommendation.